XML 131 R51.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity - Schedule of Restricted Stock and Contingent Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Number of Restricted Shares      
Granted (in shares) 400,000 300,000  
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 3.90 $ 3.58  
Restricted Stock      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 628,511    
Vested (in shares) (48,281)    
Unvested, end of period (in shares) 864,447   628,511
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 6.31    
Vested (in USD per share) 6.60    
Unvested, end of period (in USD per share) $ 5.91   $ 6.31
Unamortized compensation expense $ 3,434   $ 2,492
Weighted Average Remaining Amortization Period (Years) 2 years 1 month 6 days   1 year 9 months 18 days
Restricted Stock and Contingent Restricted Stock | Employee      
Number of Restricted Shares      
Granted (in shares) 100,000 100,000  
Restricted Stock, Performance Based      
Number of Restricted Shares      
Granted (in shares) 189,477    
Unvested, end of period (in shares) 422,884    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 4.82    
Unvested, end of period (in USD per share) $ 5.40    
Restricted Stock, Performance Based | Employee      
Number of Restricted Shares      
Granted (in shares) 200,000 100,000  
Restricted Stocks Time Vested [Member]      
Number of Restricted Shares      
Granted (in shares) 94,740    
Unvested, end of period (in shares) 441,563    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 5.73    
Unvested, end of period (in USD per share) $ 6.39    
Restricted Stocks Time Vested [Member] | Employee      
Number of Restricted Shares      
Granted (in shares) 100,000 100,000  
Contingent Restricted Stock Grants      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 150,788    
Granted (in shares) 142,112    
Unvested, end of period (in shares) 292,900   150,788
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 2.86    
Granted (in USD per share) 2.67    
Unvested, end of period (in USD per share) $ 2.77   $ 2.86
Unamortized compensation expense $ 564   $ 230
Weighted Average Remaining Amortization Period (Years) 2 years 3 months 18 days   1 year 7 months 6 days